Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
11.2M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
427K
-
Shares change
-
+123K
-
Total reported value, excl. options
-
$552K
-
Value change
-
+$144K
-
Number of buys
-
10
-
Number of sells
-
-4
-
Price
-
$1.29
Significant Holders of BioCardia, Inc. - Common Stock, par value $0.001 per share (BCDA) as of Q3 2025
21 filings reported holding BCDA - BioCardia, Inc. - Common Stock, par value $0.001 per share as of Q3 2025.
BioCardia, Inc. - Common Stock, par value $0.001 per share (BCDA) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 427K shares
of 11.2M outstanding shares and own 3.82% of the company stock.
Largest 10 shareholders include CM Management, LLC (130K shares), VANGUARD GROUP INC (96.5K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (38.8K shares), GEODE CAPITAL MANAGEMENT, LLC (38.7K shares), BROWN ADVISORY INC (35.5K shares), TWO SIGMA SECURITIES, LLC (19.3K shares), COMMONWEALTH EQUITY SERVICES, LLC (18.3K shares), WEALTH ENHANCEMENT ADVISORY SERVICES, LLC (17K shares), XTX Topco Ltd (16.2K shares), and UBS Group AG (10.7K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.